Original Article

You have full text access to this OnlineOpen article

Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway

  1. Doris R. Siwak M.S.,
  2. Shishir Shishodia Ph.D.,
  3. Bharat B. Aggarwal Ph.D.,
  4. Razelle Kurzrock M.D.†,*

Article first published online: 11 JUL 2005

DOI: 10.1002/cncr.21216

Issue

Cancer

Cancer

Volume 104, Issue 4, pages 879–890, 15 August 2005

Additional Information

How to Cite

Siwak, D. R., Shishodia, S., Aggarwal, B. B. and Kurzrock, R. (2005), Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer, 104: 879–890. doi: 10.1002/cncr.21216

Author Information

  1. Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    Fax: (713) 563-0566

*Unit 422, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402

Publication History

  1. Issue published online: 2 AUG 2005
  2. Article first published online: 11 JUL 2005
  3. Manuscript Accepted: 14 APR 2005
  4. Manuscript Revised: 7 MAR 2005
  5. Manuscript Received: 1 OCT 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (494K)

REFERENCES

  • 1
    Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 2003; 22: 3138–3151.
  • 2
    Molife R, Hancock BW. Adjuvant therapy of malignant melanoma. Crit Rev Oncol Hematol. 2002; 44: 81–102.
  • 3
    Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001; 19: 3622–3634.
  • 4
    Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19: 3635–3648.
  • 5
    Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003; 23: 363–398.
  • 6
    Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions. Anticancer Res. 2001; 21: 2895–2900.
  • 7
    Hingorani SR, Jacobetz MA, Robertson GP, Herlyn M, Tuveson DA. Suppression of BRAFV599E in human melanoma abrogates transformation. Cancer Res. 2003; 63: 5198–5202.
  • 8
    Kortylewski M, Heinrich PC, Kauffmann ME, Bohm M, MacKiewicz A, Behrmann I. Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells. Biochem J. 2001; 357: 297–303.
  • 9
    Smalley KSM, Eisen TG. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. Int J Cancer. 2002; 98: 514–522.
    Direct Link:
  • 10
    Huang S, DeGuzman A, Bucana CD, Fidler IJ. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res. 2000; 6: 2573–2581.
  • 11
    Shattuck-Brandt RL, Richmond A. Enhanced degradation of I-κBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res. 1997; 57: 3032–3039.
  • 12
    Yang J, Richmond A. Constitutive IκB kinase activity correlates with nuclear factor-κB activation in human melanoma cells. Cancer Res. 2001; 61: 4901–4909.
  • 13
    Lenardo MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989; 58: 227–229.
  • 14
    Schadendorf D, Möller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor [erratum in J Immunol. 1994;153:3360] J Immunol. 1993; 151: 2667–2675.
  • 15
    Kunsch C, Rosen CA. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol. 1993; 13: 6137–6146.
  • 16
    Stein B, Baldwin AS Jr. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol Cell Biol. 1993; 13: 7191–7198.
  • 17
    Kunsch C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J Immunol. 1994; 153: 153–164.
  • 18
    Rothwarf D, Karin M. The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE [serial on the Internet], October, 1999 [about 16 pages]. Available from http://www.stke.org/cgi/content/full/OC_sigtrans;1999/5/re1 [accessed June 22, 2005].
  • 19
    Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol. 2001; 19: 577–583.
  • 20
    Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol. 1994; 56: 554–558.
  • 21
    Davies H, Bignell GR, Cox C, et al. A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells. J Biol Chem. 2002; 277: 7920–7928.
  • 22
    Li S, Sedivy JM. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc Natl Acad Sci USA. 1993; 90: 9247–9251.
  • 23
    Folgueira L, Algeciras A, MacMorran WS, Bren GD, Paya CV. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and participates in the activation of NF-κB. J Virol. 1996; 70: 2332–2338.
  • 24
    Dhawan P, Richmond A. A novel NF-κB-inducing kinase-MAPK kinase signaling pathway up-regulates NF-κB activity in melanoma cells. J Biol Chem. 2002; 10: 7920–7928.
  • 25
    Macdonald SG, Crews CM, Wu L, et al. Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro [erratum in Mol Cell Biol. 1994;14:2223–2224]. Mol Cell Biol. 1993; 13: 6615–6620.
  • 26
    Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science. 1993; 260: 1658–1661.
  • 27
    Terada Y, Tomita K, Homma MK, et al. Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells. J Biol Chem. 1994; 269: 31296–31301.
  • 28
    Xie P, Browning DD, Hay N, Mackman N, Ye RD. Activation of NF-κB by bradykinin through a Gαq- and Gβγ-dependent pathway that involves phosphoinositide 3-kinase and Akt. J Biol Chem. 2000; 275: 24907–24914.
  • 29
    Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem. 2001; 276: 18934–18940.
  • 30
    Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW. Respiratory syncytial virus inhibits apoptosis and induces NF-κB activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem. 2002; 277: 492–501.
  • 31
    Tai YT, Podar K, Mitsiades N, et al. CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-κB signaling. Blood. 2003; 101: 2762–2769.
  • 32
    Jun T, Gjoerup O, Roberts TM. Tangled webs: evidence of cross-talk between c-Raf-1 and Akt. Sci STKE [serial on the Internet], December, 1999 [about 4 pages]. Available from http://www.stke.org/cgi/content/full/OC_sigtrans;1999/13/pe1 [accessed June 22, 2005].
  • 33
    Sheng H, Shao J, DuBois RN. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells. J Biol Chem. 2001; 276: 14498–14504.
  • 34
    Blalock WL, Navolanic PM, Steelman LS, et al. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Leukemia. 2003; 17: 1058–1067.
  • 35
    Bush JA, Cheung K-JJ Jr., Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/easpase-8 pathway independent of p53. Exp Cell Res. 2001; 271: 305–314.
  • 36
    Bender K, Göttlicher M, Whiteside S, Jobst Rahmsdorf H, Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J. 1998; 17: 5170–5181.
  • 37
    Li N, Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc Natl Acad Sci USA. 1998; 95: 13012–13017.
  • 38
    Shuto T, Xu H, Wang B, et al. Activation of NF-κB by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKKα/β-IκBα and NKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA. 2001; 98: 8774–8779.
  • 39
    Sathe SS, Sizemore N, Li X, et al. Mutant human cells with constitutive activation of NF-κB. Proc Natl Acad Sci USA. 2004; 101: 192–197.
  • 40
    Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr., Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol. 2000; 20: 1626–1638.
  • 41
    Fujita M, Norris DA, Yagi H, et al. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation, and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res. 1999; 9: 279–291.
  • 42
    Stahl JM, Cheung M, Sharma A, Trivedi NR, Shanmugam S, Robertson GP. Loss of PTEN promotes tumor development in malignant melanoma. Cancer Res. 2003; 63: 2881–2890.
  • 43
    Jetzt A, Howe JA, Horn MT, et al. Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice. Cancer Res. 2003; 63: 6697–6706.
  • 44
    Baldar CT, Macchia G, Telford JL. Interleukin-2 promoter activation in T-cells expressing activated Ha-ras. J Biol Chem. 1992; 267: 4289–4291.
  • 45
    Finco TS, Baldwin AS Jr. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J Biol Chem. 1993; 268: 17676–17679.
  • 46
    Squires MS, Hudson EA, Howells L, et al. Relevance of mitogen activated protein kinase (MAPK) and phosphatidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol. 2003; 65: 361–376.
  • 47
    Chaudhary LR, Hruska KA. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem. 2003; 89: 1–5.
    Direct Link:
  • 48
    Woo J-H, Kim Y-H, Choi Y-J, et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 2003; 24: 1199–1208.
  • 49
    Dhawan P, Singh AB, Ellis DL, Richmond A. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-□B and tumor progression. Cancer Res. 2002; 62: 7335–7342.
  • 50
    Hoffmann E, Dittrich-Breiholtz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002; 72: 847–855.
  • 51
    Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. Phil Trans R Soc London B Biol Sci. 1996; 351: 127–134.
  • 52
    Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med. 1996; 74: 589–607.
  • 53
    Kitaura J, Asai K, Maeda-Yamamoto M, Kawakami Y, Kikkawa U, Kawakami T. Akt-dependent cytokine production in mast cells. J Exp Med. 2000; 192: 729–740.
  • 54
    Kim RD, Roth TP, Darling CE, Riccardi R, Schaffer BK, Chari RS. Hypoosmotic stress stimulates growth in HepG2 cells via protein kinase B-dependent activation of activator protein-1. J Gastrointest Surg. 2001; 5: 546–555.
View Full Article (HTML) Get PDF (494K)